Nektar Therapeutics

Nektar Therapeutics

Price & Volume

Stats

See more
52W Range
$21.02-$109
Market Cap
$2.3B
Shares Short
6M

Financials

See more
Revenue (12 Mos)
$55.6M
Revenue Growth (YoY)
3.8%
Gross Profit (12 Mos)
$55.6M
Diluted EPS
-$7.93

About

CEO
Mr. Howard W. Robin
CFO
Ms. Linda M. Rubinstein M.A.
Address
455 Mission Bay Boulevard South, San Francisco, CA, United States, 94158
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
63